397 related articles for article (PubMed ID: 8632302)
1. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
3. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.
Martin PL; Wysocki RJ; Barrett RJ; May JM; Linden J
J Pharmacol Exp Ther; 1996 Feb; 276(2):490-9. PubMed ID: 8632314
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat.
Monopoli A; Casati C; Lozza G; Forlani A; Ongini E
J Pharmacol Exp Ther; 1998 Apr; 285(1):9-15. PubMed ID: 9535988
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.
Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E
Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347
[TBL] [Abstract][Full Text] [Related]
7. Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.
Dionisotti S; Ferrara S; Molta C; Zocchi C; Ongini E
J Pharmacol Exp Ther; 1996 Sep; 278(3):1209-14. PubMed ID: 8819504
[TBL] [Abstract][Full Text] [Related]
8. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
[TBL] [Abstract][Full Text] [Related]
9. [3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes.
Varani K; Gessi S; Dionisotti S; Ongini E; Borea PA
Br J Pharmacol; 1998 Apr; 123(8):1723-31. PubMed ID: 9605581
[TBL] [Abstract][Full Text] [Related]
10. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
[TBL] [Abstract][Full Text] [Related]
11. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
[TBL] [Abstract][Full Text] [Related]
12. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding.
Varani K; Gessi S; Dalpiaz A; Ongini E; Borea PA
Br J Pharmacol; 1997 Sep; 122(2):386-92. PubMed ID: 9313951
[TBL] [Abstract][Full Text] [Related]
13. Adenosine receptors involved in modulation of noradrenaline release in isolated rat tail artery.
Diniz C; Fresco P; Leal S; Gonçalves J
Eur J Pharmacol; 2004 Nov; 504(1-2):17-25. PubMed ID: 15507216
[TBL] [Abstract][Full Text] [Related]
14. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
Pinna A; Fenu S; Morelli M
Synapse; 2001 Mar; 39(3):233-8. PubMed ID: 11284438
[TBL] [Abstract][Full Text] [Related]
15. Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.
Dionisotti S; Conti A; Sandoli D; Zocchi C; Gatta F; Ongini E
Br J Pharmacol; 1994 Jun; 112(2):659-65. PubMed ID: 8075885
[TBL] [Abstract][Full Text] [Related]
16. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
Martin PL; Ueeda M; Olsson RA
J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
[TBL] [Abstract][Full Text] [Related]
17. Study of the novel non-xanthine heterocyclic compound GU285 as a potent non-selective adenosine receptor antagonist in the rat.
Harden FA; Brown L; Quinn RJ; Harrison GJ; Headrick JP; Rose'Meyer RB; Willis RJ
Arzneimittelforschung; 2002; 52(3):175-81. PubMed ID: 11963644
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
20. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus.
Cunha RA; Constantino MD; Ribeiro JA
Br J Pharmacol; 1997 Dec; 122(7):1279-84. PubMed ID: 9421273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
